Pim-1 kinase inhibits pathological injury by promoting cardioprotective signaling

Journal of Molecular and Cellular Cardiology

Volumn 51, Issue 4, 2011, Pages 554-558

  Fischer, Kimberlee M ^a   Cottage, Christopher T ^a   Konstandin, Mathias H ^a   Völkers, Mirko ^a   Khan, Mohsin ^a   Sussman, Mark A ^a  

^a SAN DIEGO STATE UNIVERSITY   (United States)

Author keywords

Cardioprotection; Kinase; Molecular signaling; Pim 1; Regeneration; Stem cell

Indexed keywords

PROTEIN KINASE B; PROTEIN KINASE PIM 1;

CELL HOMING; CELL PROLIFERATION; CELL SURVIVAL; HEART FUNCTION; HEART INFARCTION; HEART INJURY; HEART MUSCLE; HEART MUSCLE INJURY; HEART PROTECTION; HUMAN; LIFESPAN; NONHUMAN; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; STEM CELL; TISSUE INJURY; TISSUE REPAIR; TISSUE SURVIVAL;

ANIMALS; CELL PROLIFERATION; CELL SURVIVAL; HEART; HUMANS; MICE; MICE, TRANSGENIC; MYOCARDIAL INFARCTION; MYOCARDIUM; PROTO-ONCOGENE PROTEINS C-PIM-1; REGENERATION; SIGNAL TRANSDUCTION; STEM CELL TRANSPLANTATION; STEM CELLS;

EID: 80052792551     PISSN: 00222828     EISSN: 10958584     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2011.01.004     Document Type: Review

References (38)

1. Sussman M.A. Mitochondrial integrity: preservation through Akt/Pim-1 kinase signaling in the cardiomyocyte. Expert Rev Cardiovasc Ther 2009 Aug, 7(8):929-938.
2. Miyamoto S., Rubio M., Sussman M.A. Nuclear and mitochondrial signalling Akts in cardiomyocytes. Cardiovasc Res 2009 May 1, 82(2):272-285.
3. Cuypers H.T., Selten G., Quint W., Zijlstra M., Maandag E.R., Boelens W., et al. Murine leukemia virus-induced T-cell lymphomagenesis: integration of proviruses in a distinct chromosomal region. Cell 1984 May, 37(1):141-150.
4. Mikkers H., Nawijn M., Allen J., Brouwers C., Verhoeven E., Jonkers J., et al. Mice deficient for all PIM kinases display reduced body size and impaired responses to hematopoietic growth factors. Mol Cell Biol 2004 Jul, 24(13):6104-6115.
5. Padma R., Nagarajan L. The human PIM-1 gene product is a protein serine kinase. Cancer Res 1991 May 1, 51(9):2486-2489.
6. Palaty C.K., Kalmar G., Tai G., Oh S., Amankawa L., Affolter M., et al. Identification of the autophosphorylation sites of the Xenopus laevis Pim-1 proto-oncogene-encoded protein kinase. J Biol Chem 1997 Apr 18, 272(16):10514-10521.
7. Qian K.C., Wang L., Hickey E.R., Studts J., Barringer K., Peng C., et al. Structural basis of constitutive activity and a unique nucleotide binding mode of human Pim-1 kinase. J Biol Chem 2005 Feb 18, 280(7):6130-6137.
8. Bachmann M., Moroy T. The serine/threonine kinase Pim-1. Int J Biochem Cell Biol 2005 Apr, 37(4):726-730.
9. Amaravadi R., Thompson C.B. The survival kinases Akt and Pim as potential pharmacological targets. J Clin Invest 2005 Oct, 115(10):2618-2624.
10. Martelli M., Ferreri A.J., Johnson P. Primary mediastinal large B-cell lymphoma. Crit Rev Oncol Hematol 2008 Dec, 68(3):256-263.
11. Dreyfus F., Sola B., Fichelson S., Varlet P., Charon M., Tambourin P., et al. Rearrangements of the Pim-1, c-myc, and p53 genes in Friend helper virus-induced mouse erythroleukemias. Leukemia 1990 Aug, 4(8):590-594.
12. Lin YW, Beharry ZM, Hill EG, Song JH, Wang W, Xia Z, et al. A small molecule inhibitor of Pim protein kinases blocks the growth of precursor T-cell lymphoblastic leukemia/lymphoma. Blood. Jan 28; 115(4): 824-33.
13. Tong Y., Stewart K.D., Thomas S., Przytulinska M., Johnson E.F., Klinghofer V., et al. Isoxazolo[3, 4-b]quinoline-3, 4(1H, 9)-diones as unique, potent and selective inhibitors for Pim-1 and Pim-2 kinases: chemistry, biological activities, and molecular modeling. Bioorg Med Chem Lett 2008 Oct 1, 18(19):5206-5208.
14. Eichmann A., Yuan L., Breant C., Alitalo K., Koskinen P.J. Developmental expression of pim kinases suggests functions also outside of the hematopoietic system. Oncogene 2000 Feb 24, 19(9):1215-1224.
15. Wang Z., Bhattacharya N., Weaver M., Petersen K., Meyer M., Gapter L., et al. Pim-1: a serine/threonine kinase with a role in cell survival, proliferation, differentiation and tumorigenesis. J Vet Sci 2001 Dec, 2(3):167-179.
16. Klejman A., Schreiner S.J., Nieborowska-Skorska M., Slupianek A., Wilson M., Smithgall T.E., et al. The Src family kinase Hck couples BCR/ABL to STAT5 activation in myeloid leukemia cells. EMBO J 2002 Nov 1, 21(21):5766-5774.
17. van Lohuizen M., Verbeek S., Krimpenfort P., Domen J., Saris C., Radaszkiewicz T., et al. Predisposition to lymphomagenesis in pim-1 transgenic mice: cooperation with c-myc and N-myc in murine leukemia virus-induced tumors. Cell 1989 Feb 24, 56(4):673-682.
18. van Lohuizen M., Verbeek S., Scheijen B., Wientjens E., van der Gulden H., Berns A. Identification of cooperating oncogenes in E mu-myc transgenic mice by provirus tagging. Cell 1991 May 31, 65(5):737-752.
19. Amson R., Sigaux F., Przedborski S., Flandrin G., Givol D., Telerman A. The human protooncogene product p33pim is expressed during fetal hematopoiesis and in diverse leukemias. Proc Natl Acad Sci USA 1989 Nov, 86(22):8857-8861.
20. Muraski J.A., Rota M., Misao Y., Fransioli J., Cottage C., Gude N., et al. Pim-1 regulates cardiomyocyte survival downstream of Akt. Nat Med 2007 Dec, 13(12):1467-1475.
21. Ionov Y., Le X., Tunquist B.J., Sweetenham J., Sachs T., Ryder J., et al. Pim-1 protein kinase is nuclear in Burkitt's lymphoma: nuclear localization is necessary for its biologic effects. Anticancer Res 2003 Jan-Feb, 23(1A):167-178.
22. Borillo GA, Mason M, Quijada P, Volkers M, Cottage C, McGregor M, et al. Pim-1 kinase protects mitochondrial integrity in cardiomyocytes. Circ Res. Apr 16; 106(7): 1265-74.
23. Cottage CT, Bailey B, Fischer KM, Avitable D, Collins B, Tuck S, et al. Cardiac progenitor cell cycling stimulated by pim-1 kinase. Circ Res. Mar 19; 106(5): 891-901.
24. Fischer K.M., Cottage C.T., Wu W., Din S., Gude N.A., Avitabile D., et al. Enhancement of myocardial regeneration through genetic engineering of cardiac progenitor cells expressing Pim-1 kinase. Circulation 2009, 120(21):2077-2087.
25. Muraski J.A., Fischer K.M., Wu W., Cottage C.T., Quijada P., Mason M., et al. Pim-1 kinase antagonizes aspects of myocardial hypertrophy and compensation to pathological pressure overload. Proc Natl Acad Sci USA 2008, 105(37):13889-13894.
26. Willert M, Augstein A, Poitz DM, Schmeisser A, Strasser RH, Braun-Dullaeus RC. Transcriptional regulation of Pim-1 kinase in vascular smooth muscle cells and its role for proliferation. Basic Res Cardiol. Mar; 105(2): 267-77.
27. Bhattacharya N., Wang Z., Davitt C., McKenzie I.F., Xing P.X., Magnuson N.S. Pim-1 associates with protein complexes necessary for mitosis. Chromosoma 2002, 111(2):80-95.
28. Zippo A., De Robertis A., Bardelli M., Galvagni F., Oliviero S. Identification of Flk-1 target genes in vasculogenesis: Pim-1 is required for endothelial and mural cell differentiation in vitro. Blood 2004, 103(12):4536-4544.
29. Xie Y., Xu K., Dai B., Guo Z., Jiang T., Chen H., et al. The 44kDa Pim-1 kinase directly interacts with tyrosine kinase Etk/BMX and protects human prostate cancer cells from apoptosis induced by chemotherapeutic drugs. Oncogene 2006, 25(1):70-78.
30. Bailey B., Izarra A., Alvarez R., Fischer K.M., Cottage C.T., Quijada P., et al. Cardiac stem cell genetic engineering using the alphaMHC promoter. Regen Med 2009, 4(6):823-833.
31. Ma J., Arnold H.K., Lilly M.B., Sears R.C., Kraft A.S. Negative regulation of Pim-1 protein kinase levels by the B56beta subunit of PP2A. Oncogene 2007, 26(35):5145-5153.
32. Schmidt T., Karsunky H., Rodel B., Zevnik B., Elsasser H.P., Moroy T. Evidence implicating Gfi-1 and Pim-1 in pre-T-cell differentiation steps associated with beta-selection. EMBO J 1998, 17(18):5349-5359.
33. Lilly M., Sandholm J., Cooper J.J., Koskinen P.J., Kraft A. The PIM-1 serine kinase prolongs survival and inhibits apoptosis-related mitochondrial dysfunction in part through a bcl-2-dependent pathway. Oncogene 1999, 18(27):4022-4031.
34. Bachmann M., Kosan C., Xing P.X., Montenarh M., Hoffmann I., Moroy T. The oncogenic serine/threonine kinase Pim-1 directly phosphorylates and activates the G2/M specific phosphatase Cdc25C. Int J Biochem Cell Biol 2006, 38(3):430-443.
35. Mochizuki T., Kitanaka C., Noguchi K., Muramatsu T., Asai A., Kuchino Y. Physical and functional interactions between Pim-1 kinase and Cdc25A phosphatase. Implications for the Pim-1-mediated activation of the c-Myc signaling pathway. J Biol Chem 1999, 274(26):18659-18666.
36. Wang Z., Bhattacharya N., Mixter P.F., Wei W., Sedivy J., Magnuson N.S. Phosphorylation of the cell cycle inhibitor p21Cip1/WAF1 by Pim-1 kinase. Biochim Biophys Acta 2002, 1593(1):45-55.
37. Beltrami A.P., Urbanek K., Kajstura J., Yan S.M., Finato N., Bussani R., et al. Evidence that human cardiac myocytes divide after myocardial infarction. N Engl J Med 2001, 344(23):1750-1757.
38. Chen J., Kobayashi M., Darmanin S., Qiao Y., Gully C., Zhao R., et al. Hypoxia-mediated up-regulation of Pim-1 contributes to solid tumor formation. Am J Pathol 2009, 175(1):400-411.